SCHEMBL932293

SCHEMBL932293

CC(C)(N)C(NC(=O)c1ccc(C#CC#CC2CC2)cc1)C(=O)NO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13245191 1.00 — —
SCHEMBL932292 1.00 — —
SCHEMBL13245610 0.99 — —
SCHEMBL13245216 0.96 — —
SCHEMBL13245245 0.96 — —
SCHEMBL13245141 0.96 — —
SCHEMBL13244929 0.96 — —
SCHEMBL13738316 0.93 — —
SCHEMBL13245597 0.93 — —
SCHEMBL13245099 0.93 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120283175-A1 ANTIBACTERIAL COMPOSITIONS ACHAOGEN, INC. (US) 2012-11-08 — — US claimed
WO-2011005355-A1 COMBINATIONS COMPRISING A LPXC INHIBITOR AND AN ANTIBIOTIC FOR USE IN THE TREATMENT OF INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA ACHAOGEN, INC. (US) 2011-01-13 — — WO claimed
US-9617256-B2 Antibacterial agents ACHAOGEN, INC. (US) 2017-04-11 — — US disclosed
US-20120283175-A1 ANTIBACTERIAL COMPOSITIONS ACHAOGEN, INC. (US) 2012-11-08 — — US disclosed
WO-2011005355-A1 COMBINATIONS COMPRISING A LPXC INHIBITOR AND AN ANTIBIOTIC FOR USE IN THE TREATMENT OF INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA ACHAOGEN, INC. (US) 2011-01-13 — — WO disclosed
US-20100190766-A1 ANTIBACTERIAL AGENTS ACHAOGEN, INC. (US) 2010-07-29 — — US disclosed
US-20100190766-A1 ANTIBACTERIAL AGENTS ACHAOGEN, INC. (US) 2010-07-29 — — US disclosed
Send feedback